POLAR NanoPharma
Nanomedical Solutions for Oncology
An Innovative Nanotechnology Platform for Oncology Applications
Polar NanoPharma is developing proprietary polymeric nanocapsules to improve the delivery of anticancer therapies. Based on Ecostratar Technology, our one-pot aqueous platform enables the creation of robust polycarbamate/polyurea-based nanovehicles capable of encapsulating therapeutic payloads without chemical modification.
By tuning capsule composition, size, surface properties and release behavior, our platform is designed to enhance tumor delivery, promote intracellular release and improve the therapeutic index of oncology drugs. Our mission is to transform promising anticancer agents into safer, more effective nanomedicines for patients with solid tumors.
Technology
The potential of polymeric nanotechnology applied to meet medical challenges
ECOSTRATAR is a pioneering nanotechnological platform revolutionizing delivery systems. Our focus on developing water-based polycarbamate-polyurea nanocapsule dispersions marks a transformative step towards addressing diverse human needs with main focus in Oncology.
Products powered by ECOSTRATAR harness the stratification and ordering capabilities of self-emulsifiable rationally pre-designed amphiphilic polycarbamate-polyurea reactive pre-polymers in interfaces. With our nanotechnology platform we can adjust multiparametric features such as, particle size, stability, functionalization, depending on each individual application.
Committed to sustainable innovation, our nanotechnology platform integrates eco-friendly chemistry with scalable industrial processes, making it the future of drug delivery and advanced material science.
Clean & Scalable
Production Process
Efficient Water-Based and
One-Pot Synthetic Method. Free of Intermediate Steps and External Surfactants
Drug Stabilization
& Protection
Prevent Early Drug Degradation
and Leakage During Drug Circulation
Biocompatible & biodegradable
Safe Polymers that Enhance Drug Biodistribution and Reduce Systemic Drug-Related Toxicity and Side Effects
Versatile Platform
Designed Nanoparticles are Capable of Encapsulating a Broad Range of Molecules with Diverse Physicochemical Properties and without need of chemical modification. Including Small Molecules, Metal Complexes, Peptides or Proteins. Gene Therapies Under Investigation
TARGETED ACCUMULATION
Engineered Smart Nanoparticles Enhance Accumulation and Internalization in Response to local pH Changes, Creating an Ideal System for Targeting Tumor Lesions
STIMULATED RELEASE
Rationally Designed Polymers in Nanoparticle Shells Enable Targeted Drug Delivery with Biodegradable Groups for Controlled Release in Cancerous Cells
pipeline
Our nanotechnology has been extensively tested in various oncological applications,
showing significant potential in cancer treatment and diagnosis.
Team
Iván Ramos Tomillero, PhD, MBA
CEO and Co-founder
Josep Rocas Sorolla, PhD
CSO and Co-founder
POLAR NanoPharma will benefit from the synergistic collaboration with Ecopol Tech. This strategic partnership aim to drive innovation in nanotechnology, delivering groundbreaking solutions in pharmaceutical development and oncology drug delivery systems
Neus Isidro
CEO Encapsulation Systems
Haroon Muhammad
CEO Advanced Polymers & Scale-up
Anna Pros
Quality Control & Regulatory Affairs
Oriol Torres
R&D Encapsulation Systems
Neus Santiago
R&D Ecostratar Platform
Advisory board
Building Our Scientific Advisory Board
We are currently in the process of selecting a distinguished Scientific Advisory Board.
Our goal is to assemble a multidisciplinary panel of leading experts who will provide strategic insights and innovative solutions for advancing our oncological applications.
Empowered by Startup Ecosystem Programs
CERTIFICATIONS
